Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages — Stella

Home/Recurrent Miscarriage/

View on ClinicalTrials.gov

Recruiting

Back to Recurrent Miscarriage trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Netherlands

Leiden University Medical Center, Leiden, South Holland

Key details

Phase

Post-approval study

Sponsor

Leiden University Medical Center

Collaborators

Amsterdam University Medical Center, Erasmus Medical Center

Enrollment target

~490 participants

Started

January 2024

Primary completion

July 2026

Age range

18 Years – 40 Years

Sex

Female only

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.